Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC. Hepatol Commun. 2022 07; 6(7):1776-1785.
View in:
PubMed
subject areas
Carcinoma, Hepatocellular
Humans
Liver Neoplasms
Retrospective Studies
Treatment Outcome
authors with profiles
Anjana Pillai